Annals of internal medicine
-
There currently is debate regarding whether U. S. institutions and clinicians may or should restrict patient access to COVID-19 drugs and vaccines that have been granted emergency use authorization by the U. ⋯ Food and Drug Administration. The authors provide their views on the legal, ethical, and clinical ramifications of such restriction.
-
Heerspink HJ, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436-46. 32970396.
-
Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 Severity Index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76:442-53. 33012378.